Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6786) 6786
Book Review (1791) 1791
Publication (719) 719
Newsletter (119) 119
Newspaper Article (104) 104
Book Chapter (61) 61
Web Resource (29) 29
Book / eBook (28) 28
Conference Proceeding (24) 24
Dissertation (8) 8
Magazine Article (7) 7
Trade Publication Article (7) 7
Data Set (2) 2
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5965) 5965
multiple sclerosis (5341) 5341
humans (4919) 4919
female (3169) 3169
neurosciences (2818) 2818
male (2716) 2716
adult (2400) 2400
animals (2250) 2250
middle aged (1971) 1971
immunology (1763) 1763
clinical neurology (1730) 1730
experimental autoimmune encephalomyelitis (1517) 1517
multiple-sclerosis (1503) 1503
neurology (1368) 1368
central-nervous-system (1205) 1205
mice (1105) 1105
multiple sclerosis - metabolism (1025) 1025
inflammation (1015) 1015
multiple sclerosis - pathology (949) 949
multiple sclerosis - immunology (916) 916
experimental allergic encephalomyelitis (874) 874
research (858) 858
disease (825) 825
analysis (795) 795
multiple sclerosis - drug therapy (787) 787
magnetic resonance imaging (689) 689
brain (645) 645
expression (635) 635
young adult (602) 602
cytokines (591) 591
disease models, animal (586) 586
care and treatment (568) 568
t cells (568) 568
autoimmunity (559) 559
aged (553) 553
demyelination (547) 547
health aspects (544) 544
mice, inbred c57bl (542) 542
t-cells (538) 538
brain - pathology (531) 531
multiple sclerosis - physiopathology (530) 530
development and progression (526) 526
lymphocytes (513) 513
pharmacology & pharmacy (513) 513
cerebrospinal-fluid (501) 501
article (493) 493
cell biology (491) 491
multiple sclerosis - genetics (489) 489
autoimmune diseases (481) 481
biochemistry & molecular biology (479) 479
disease progression (479) 479
encephalomyelitis, autoimmune, experimental - immunology (477) 477
cells, cultured (475) 475
physiological aspects (465) 465
central nervous system (462) 462
case-control studies (451) 451
adolescent (449) 449
gene expression (448) 448
encephalomyelitis (446) 446
medicine (446) 446
nervous system (445) 445
allergy and immunology (423) 423
research article (423) 423
pathogenesis (422) 422
pathology (413) 413
multiple sclerosis, relapsing-remitting - drug therapy (410) 410
risk factors (405) 405
encephalomyelitis, autoimmune, experimental - pathology (401) 401
proteins (398) 398
multiple sclerosis - blood (397) 397
cytokines - metabolism (395) 395
disability (394) 394
medicine & public health (391) 391
lesions (390) 390
brain - metabolism (386) 386
interferon (379) 379
neurodegeneration (375) 375
sclerosis (374) 374
medical research (371) 371
abridged index medicus (367) 367
multiple sclerosis, relapsing-remitting - immunology (366) 366
activation (365) 365
rats (364) 364
multidisciplinary sciences (358) 358
review (357) 357
encephalomyelitis, autoimmune, experimental - metabolism (348) 348
patients (348) 348
double-blind (340) 340
cells (338) 338
genetic aspects (338) 338
biomedicine (334) 334
biomarkers (330) 330
multiple sclerosis - diagnosis (328) 328
multiple sclerosis, relapsing-remitting - metabolism (326) 326
rodents (322) 322
time factors (320) 320
t-lymphocytes - immunology (310) 310
interferon-beta - therapeutic use (309) 309
oxidative stress (309) 309
dendritic cells (308) 308
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7073) 7073
Spanish (11) 11
Russian (10) 10
Turkish (5) 5
German (4) 4
Chinese (2) 2
French (2) 2
Hungarian (1) 1
Italian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Multiple Sclerosis: MicroRNA Expression Profiles Accurately Differentiate Patients with Relapsing-Remitting Disease from Healthy Controls
by Keller, Andreas and Leidinger, Petra and Lange, Julia and Borries, Anne and Schroers, Hannah and Scheffler, Matthias and Lenhof, Hans-Peter and Ruprecht, Klemens and Meese, Eckart
PLoS ONE, ISSN 1932-6203, 2009, Volume 4, Issue 10, pp. e7440 - e7440
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system, which is heterogenous with respect to clinical... 
BIOLOGY | Biomarkers - metabolism | Reproducibility of Results | Oligonucleotide Array Sequence Analysis | Area Under Curve | Humans | Male | Gene Expression Profiling | Inflammation | Case-Control Studies | Multiple Sclerosis, Relapsing-Remitting - genetics | MicroRNAs | Sensitivity and Specificity | Female | Cell Differentiation | Software | Multiple Sclerosis, Relapsing-Remitting - metabolism | Medicine, Experimental | Medical research | Multiple sclerosis | MicroRNA | Analysis | Deregulation | Disease | Basis functions | Pathogenesis | Central nervous system | Medical diagnosis | Stomach cancer | Blood | Sclerosis | Demyelination | Bioindicators | Labeling | Hypothesis testing | Medical treatment | Blood cells | MiRNA | Gene expression | Disease control | Patients | Radial basis function | Support vector machines | Sensitivity | Ribonucleic acids | Rheumatoid arthritis | Pancreatic cancer | Biomarkers | Prostate | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Serum NADPH oxidase concentrations and the associations with iron metabolism in relapsing remitting multiple sclerosis
by Doğan, Halef Okan and Yildiz, Özlem Kayim
Journal of Trace Elements in Medicine and Biology, ISSN 0946-672X, 09/2019, Volume 55, pp. 39 - 43
Overproduction of reactive oxygen species (ROS) and impaired iron metabolism are considered to be possible factors in the pathogenesis of Multiple sclerosis... 
Multiple sclerosis | Iron | NADPH oxidase | Ferritin | Oxidases | Phosphates | Niacinamide | Medical research | C-reactive protein | Physiological aspects | Medicine, Experimental | Blood cell count | Protein binding | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Oxidative Stress Related to Iron Metabolism in Relapsing Remitting Multiple Sclerosis Patients With Low Disability
by Siotto, M and Filippi, MM and Simonelli, I and Landi, D and Ghazaryan, A and Vollaro, S and Ventriglia, M and Pasqualetti, P and Rongioletti, MCA and Squitti, R and Vernieri, F
FRONTIERS IN NEUROSCIENCE, ISSN 1662-453X, 02/2019, Volume 13, pp. 86 - 86
Oxidative status may play a role in chronic inflammation and neurodegeneration which are considered critical etiopathogenetic factors in Multiple Sclerosis... 
ANTIOXIDANT ACTIVITY | ceruloplasmin | ceruloplasmin:transferrin ratio | LIPID-PEROXIDATION | multiple sclerosis | ALZHEIMERS-DISEASE | NEUROSCIENCES | SERUM CERULOPLASMIN | iron metabolism | TRANSFERRIN | WILSONS-DISEASE | D-ROMS TEST | CEREBROSPINAL VENOUS INSUFFICIENCY | FERRITIN | ASSOCIATION | oxidative stress | total antioxidant status | hydroperoxides | Physiological aspects | Multiple sclerosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS
by Kirov, Ivan I and Tal, Assaf and Babb, James S and Herbert, Joseph and Gonen, Oded
Neurology, ISSN 0028-3878, 01/2013, Volume 80, Issue 1, pp. 39 - 46
Objective: To characterize and follow the diffuse gray and white matter (GM/WM) metabolic abnormalities in early relapsing-remitting multiple sclerosis using... 
MULTIPLE-SCLEROSIS | ATROPHY | ABNORMALITIES | GREY-MATTER | MAGNETIC-RESONANCE | BRAIN | DAMAGE | LESIONS | CLINICAL NEUROLOGY | Disability Evaluation | Nerve Fibers, Myelinated - metabolism | Protons | Magnetic Resonance Spectroscopy - methods | Follow-Up Studies | Inositol - metabolism | Humans | Male | Functional Neuroimaging - methods | Case-Control Studies | Brain - metabolism | Nerve Fibers, Unmyelinated - metabolism | Choline | Creatine - metabolism | Adult | Aspartic Acid - metabolism | Female | Aspartic Acid - analogs & derivatives | Functional Neuroimaging - statistics & numerical data | Multiple Sclerosis, Relapsing-Remitting - metabolism | Index Medicus | Abridged Index Medicus | 125 | 130 | 120
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Targeting phosphocreatine metabolism in relapsing-remitting multiple sclerosis: evaluation with brain MRI, H-1 and P-31 MRS, and clinical and cognitive testing
by Cambron, M and Reynders, T and Debruyne, J and Reyngoudt, H and Ribbens, A and Achten, E and Laureys, G
JOURNAL OF NEUROLOGY, ISSN 0340-5354, 11/2018, Volume 265, Issue 11, pp. 2614 - 2624
Background/objectives Fluoxetine and prucalopride might change phosphocreatine (PCr) levels via the cAMP-PKA pathway, an interesting target in the... 
CONTROLLED-TRIAL | Multiple sclerosis | WHITE-MATTER | Fluoxetine | TRANSCRIPTION | IMMUNOPATHOLOGY | Prucalopride | Phosphocreatine | ASTROCYTES | CLINICAL NEUROLOGY | Magnetic resonance spectroscopy | HIPPOCAMPUS | CREATINE-KINASE GENE | MAGNETIC-RESONANCE-SPECTROSCOPY | RECEPTORS
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Targeting phosphocreatine metabolism in relapsing--remitting multiple sclerosis: evaluation with brain MRI, 1.sup.H and 31.sup.P MRS, and clinical and cognitive testing
by Cambron, Melissa and Reynders, Tatjana and Debruyne, Jan and Reyngoudt, Harmen and Ribbens, Annemie and Achten, Erik and Laureys, Guy
Journal of Neurology, ISSN 0340-5354, 11/2018, Volume 265, Issue 11, p. 2614
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00415-018-9039-9... 
Complications and side effects | Multiple sclerosis | Usage | Fluoxetine | Nuclear magnetic resonance spectroscopy | Dosage and administration | Genetic aspects | Diagnosis | Research | Drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Regional neuronal activity in patients with relapsing remitting multiple sclerosis
by Baumgartner, Annette and Frings, Lars and Schiller, Florian and Stich, Oliver and Mix, Michael and Egger, Karl and Schluh, Gisa and Rauer, Sebastian and Meyer, Philipp T
Acta Neurologica Scandinavica, ISSN 0001-6314, 12/2018, Volume 138, Issue 6, pp. 466 - 474
Objectives Although interferon-beta is an established drug for relapsing remitting multiple sclerosis (RRMS), its impact on neuronal activity is not well... 
fatigue | interferon‐beta | cerebral glucose metabolism | multiple sclerosis | interferon-beta | DEPRESSION | BASAL GANGLIA | COGNITIVE IMPAIRMENT | CLINICAL NEUROLOGY | GLUCOSE | INTERFERON BETA-1B | CENTRAL-NERVOUS-SYSTEM | CHEMOKINE RECEPTORS | PET | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Humans | Middle Aged | Male | Positron-Emission Tomography - methods | Brain - drug effects | Brain - metabolism | Interferon-beta - therapeutic use | Neuropsychological Tests | Adult | Female | Neurons - metabolism | Neurons - drug effects | Multiple Sclerosis, Relapsing-Remitting - metabolism | Immunologic Factors - therapeutic use | Medical research | Relapse | Multiple sclerosis | PET imaging | Neurons | Depression, Mental | Glucose | Biological response modifiers | Dextrose | Diseases | Neurophysiology | Glucose metabolism | Medicine, Experimental | Interferon | Metabolic rate | Cerebellum | Cortex (cingulate) | Cortex (occipital) | Fatigue | Mental depression | Patients | Cortex (parietal) | Cortex (frontal) | Neostriatum | Superior temporal sulcus | Positron emission tomography | Cortex (temporal) | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Reduced GABA levels correlate with cognitive impairment in patients with relapsing-remitting multiple sclerosis
by Cao, Guanmei and Edden, Richard A. E and Gao, Fei and Li, Hao and Gong, Tao and Chen, Weibo and Liu, Xiaohui and Wang, Guangbin and Zhao, Bin
European Radiology, ISSN 0938-7994, 3/2018, Volume 28, Issue 3, pp. 1140 - 1148
To investigate if brain gamma-aminobutyric acid (GABA) levels in patients with relapsing-remitting multiple sclerosis (RRMS) are abnormal compared with healthy... 
MEGA-PRESS | Multiple sclerosis | 1 H-MRS | Medicine & Public Health | Diagnostic Radiology | GABA | Internal Medicine | Interventional Radiology | Imaging / Radiology | Ultrasound | Neuroradiology | Cognitive impairment | H-MRS | ATTENTION | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | PARVALBUMIN | MAGNETIC-RESONANCE-SPECTROSCOPY | INDIVIDUAL-DIFFERENCES | CINGULATE CORTEX | DISABILITY | MOTOR CORTEX | GAMMA-AMINOBUTYRIC-ACID | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | INTERNEURONS | H-1-MRS | Severity of Illness Index | Magnetic Resonance Spectroscopy - methods | gamma-Aminobutyric Acid - metabolism | Cognitive Dysfunction - metabolism | Humans | Middle Aged | Male | Cognitive Dysfunction - etiology | Temporal Lobe - metabolism | Case-Control Studies | Gyrus Cinguli - metabolism | Brain - metabolism | Neuropsychological Tests | Magnetic Resonance Imaging | Multiple Sclerosis, Relapsing-Remitting - psychology | Prefrontal Cortex - metabolism | Adult | Female | Multiple Sclerosis, Relapsing-Remitting - metabolism | Nuclear magnetic resonance spectroscopy | Care and treatment | Relapse | Diseases | Brain | Cortex (prefrontal) | Spectroscopy | Cortex (cingulate) | Pathogenesis | Abnormalities | Magnetic resonance | Cognitive ability | Impairment | Patients | Magnetic resonance spectroscopy | γ-Aminobutyric acid | Spectrum analysis | Interferon | Hippocampus | Neurotransmission | Index Medicus | 1H-MRS
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
by Romme Christensen, Jeppe and Börnsen, Lars and Hesse, Dan and Krakauer, Martin and Sørensen, Per S and Søndergaard, Helle B and Sellebjerg, Finn
Journal of Neuroinflammation, ISSN 1742-2094, 09/2012, Volume 9, Issue 1, pp. 215 - 215
Background: Numerous cytokines are implicated in the immunopathogenesis of multiple sclerosis (MS), but studies are often limited to whole blood (WB) or... 
Relapsing-remitting multiple sclerosis | Immunology | Cytokines | Real-time PCR | Cerebrospinal fluid cells | Blood | CD80 B7-1 | DENDRITIC CELLS | MESSENGER-RNA EXPRESSION | INTERFERON-BETA | CEREBROSPINAL-FLUID | NEUROSCIENCES | FACTOR-ALPHA | B-CELLS | FLUID MONONUCLEAR-CELLS | TUMOR-NECROSIS-FACTOR | T-CELLS | Multiple Sclerosis, Relapsing-Remitting - pathology | Cytokines - metabolism | Humans | Middle Aged | Blood Cells - metabolism | Gene Expression Regulation - physiology | Male | RNA, Messenger - metabolism | Adult | Female | Blood Cells - classification | Cytokines - genetics | Multiple Sclerosis, Relapsing-Remitting - metabolism | Somatotropin | Multiple sclerosis | Dendritic cells | Genes | T cells | Gene expression | Pharmaceutical industry | Studies | Councils | Pathogenesis | Genomics | Life sciences | Manuscripts | Immune system | Index Medicus | Lymphotoxin | CD19 antigen | Immunoregulation | Interleukin 23 | Inflammation | Cerebrospinal fluid | CD14 antigen | Interleukin 15 | Interleukin 27 | CD4 antigen | Interleukin 7 | Monocytes | Interleukins | Lymphocytes B | Immunopathogenesis | Interleukin 1 | Interleukin 10 | Peripheral blood mononuclear cells | gamma -Interferon | Remission
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: Interleukin-17A and interleukin-17F serum levels
by Babaloo, Zohreh and Aliparasti, Mohammad Reza and Babaiea, Farhad and Almasi, Shohreh and Baradaran, Behzad and Farhoudi, Mehdi
Immunology Letters, ISSN 0165-2478, 2015, Volume 164, Issue 2, pp. 76 - 80
Abstract Background and aims Multiple sclerosis (MS) is an inflammatory condition of the central nervous system, with genetic and environmental factors having... 
Allergy and Immunology | Multiple Sclerosis | Relapsing-remitting MS | IL-17F | IL-17A | Th17 | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | INFLAMMATORY RESPONSES | MONONUCLEAR-CELLS | INTERFERON-BETA | IMMUNOLOGY | HELPER 17 CELLS | DEMYELINATING DISEASE | IL-17 | CENTRAL-NERVOUS-SYSTEM | T-CELLS | BLOOD | Interleukin-17 - blood | Multiple Sclerosis, Relapsing-Remitting - immunology | Multiple Sclerosis, Relapsing-Remitting - blood | Humans | Male | Multiple Sclerosis, Relapsing-Remitting - diagnosis | Case-Control Studies | Young Adult | Th17 Cells - metabolism | Th17 Cells - immunology | Adult | Female | Multiple Sclerosis, Relapsing-Remitting - metabolism | Development and progression | Multiple sclerosis | Care and treatment | Relapse | Interleukins | Diseases | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial
by Mähler, Anja and Mähler, Anja and Steiniger, Jochen and Steiniger, Jochen and Bock, Markus and Bock, Markus and Klug, Lars and Klug, Lars and Parreidt, Nadine and Parreidt, Nadine and Lorenz, Mario and Lorenz, Mario and Zimmermann, Benno F and Zimmermann, Benno F and Krannich, Alexander and Krannich, Alexander and Paul, Friedemann and Paul, Friedemann and Boschmann, Michael and Boschmann, Michael
American Journal of Clinical Nutrition, ISSN 0002-9165, 03/2015, Volume 101, Issue 3, pp. 487 - 495
Background: Muscle weakness and fatigue are common symptoms in multiple sclerosis (MS). Green tea catechins such as (-)epigallocatechin-3-gallate (EGCG) are... 
epigallocatechin-3-gallate | calorimetry | microdialysis | sex difference | multiple sclerosis | energy metabolism | MENSTRUAL-CYCLE | CAFFEINE | EXERCISE | GREEN TEA EXTRACT | CATECHOL-O-METHYLTRANSFERASE | FAT OXIDATION | NUTRITION & DIETETICS | ENERGY-EXPENDITURE | INHIBITION | EXPRESSION | FOOD | Neuroprotective Agents - therapeutic use | Carbohydrate Metabolism - drug effects | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Glatiramer Acetate | Male | Muscle, Skeletal - metabolism | Motor Activity | Muscle, Skeletal - drug effects | Postprandial Period | Adult | Catechin - therapeutic use | Female | Dietary Supplements - adverse effects | Neuroprotective Agents - adverse effects | Catechin - adverse effects | Multiple Sclerosis, Relapsing-Remitting - metabolism | Severity of Illness Index | Double-Blind Method | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Multiple Sclerosis, Relapsing-Remitting - physiopathology | Sex Characteristics | Combined Modality Therapy - adverse effects | Cross-Over Studies | Subcutaneous Fat, Abdominal - drug effects | Lipid Metabolism - drug effects | Immunosuppressive Agents - adverse effects | Multiple Sclerosis, Relapsing-Remitting - diet therapy | Catechin - analogs & derivatives | Subcutaneous Fat, Abdominal - metabolism | Energy Metabolism - drug effects | Peptides - adverse effects | Peptides - therapeutic use | Catechin | Multiple sclerosis | Clinical trials | Physiological aspects | Muscles | Glucose | Green tea | Dextrose | Care and treatment | Energy metabolism | Bioenergetics | Health aspects | Tea | Oxidation | Exercise | Metabolism | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration
by La Rocca, Claudia and Carbone, Fortunata and De Rosa, Veronica and Colamatteo, Alessandra and Galgani, Mario and Perna, Francesco and Lanzillo, Roberta and Brescia Morra, Vincenzo and Orefice, Giuseppe and Cerillo, Ilaria and Florio, Ciro and Maniscalco, Giorgia Teresa and Salvetti, Marco and Centonze, Diego and Uccelli, Antonio and Longobardi, Salvatore and Visconti, Andrea and Matarese, Giuseppe
Metabolism, ISSN 0026-0495, 12/2017, Volume 77, pp. 39 - 46
Metabolic reprogramming is shaped to support specific cell functions since cellular metabolism controls the final outcome of immune response. Multiple... 
Adipocytokines | IFN beta-1a | Multiple sclerosis | Metabolism | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | ACTIVATION | RECEPTOR | OSTEOPROTEGERIN | INTERFERON-BETA | CEREBROSPINAL-FLUID | INFLAMMATION | ENDOCRINOLOGY & METABOLISM | GLATIRAMER ACETATE | LIGAND | Interferon beta-1a - therapeutic use | Multiple Sclerosis, Relapsing-Remitting - immunology | Lymphocyte Activation | Humans | Middle Aged | Oxidative Phosphorylation | Glucose Transporter Type 1 - metabolism | Male | Mitochondria - metabolism | Glycolysis - drug effects | Case-Control Studies | Young Adult | T-Lymphocytes - metabolism | Glucose Transporter Type 1 - drug effects | Adult | Female | T-Lymphocytes - pathology | Multiple Sclerosis, Relapsing-Remitting - metabolism | Glucose metabolism | Enzymes | Relapse | Physiological aspects | Interferon | Biological response modifiers | T cells | Diseases | Index Medicus | OCR, oxygen consumption rate | Th, T helper | E2, exone2 | MPO, myeloperoxidase | CIA, collagen-induced arthritis | DLAT, dihydrolipoamide S-acetyltransferase | BMI, body mass index | sICAM-1, soluble ICAM-1 | Tconv, conventional T cells | MCP-1, monocyte chemoattractant protein-1 | PBMCs, peripheral blood mononuclear cells | IFN, interferon | Treg, regulatory T cells | OPG, osteoprotegerin | RANKL, receptor activator of nuclear factor kappaB ligand | T1D, type 1 diabetes | sCD40L, soluble CD40 ligand | RR, relapsing remitting | sTNF-R, soluble tumor necrosis factor receptor | MS, multiple sclerosis | CNS, central nervous system | iTreg, inducible regulatory T cells | ECAR, extracellular acidification rate | sLeptinR, soluble leptin receptor | DLST, dihydrolipoamide succinyltransferase | TCR, T cell receptor | EAE, experimental autoimmune encephalomyelitis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Enhanced Axonal Metabolism during Early Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis
by Wiebenga, O.T and Klauser, A.M and Schoonheim, M.M and Nagtegaal, G.J.A and Steenwijk, M.D and van Rossum, J.A and Polman, C.H and Barkhof, F and Pouwels, P.J.W and Geurts, J.J.G
American Journal of Neuroradiology, ISSN 0195-6108, 2015, Volume 36, Issue 6, pp. 1116 - 1123
BACKGROUND AND PURPOSE: The considerable clinical effect of natalizumab in patients with relapsing-remitting multiple sclerosis might be explained by its... 
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | GRAY | APPEARING WHITE-MATTER | MAGNETIC-RESONANCE-SPECTROSCOPY | QUANTIFICATION | PLACEBO-CONTROLLED TRIAL | NEUROIMAGING | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | LESIONS | DAMAGE | BRAIN | CLINICAL NEUROLOGY | Magnetic Resonance Spectroscopy - methods | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Humans | Image Interpretation, Computer-Assisted - methods | Middle Aged | Axons - drug effects | Axons - metabolism | Male | Brain - drug effects | Brain - metabolism | Interferon-beta - therapeutic use | Early Medical Intervention | Axons - pathology | Glatiramer Acetate - therapeutic use | Natalizumab - therapeutic use | Brain - pathology | Adult | Female | Image Enhancement - methods | Longitudinal Studies | Energy Metabolism - drug effects | Multiple Sclerosis, Relapsing-Remitting - metabolism | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights